文献速递乳腺乳腺X线

移动乳腺X线筛查与城市医院筛查的诊断解决时间比较

Time to Diagnostic Resolution in Mobile Mammography Versus Urban Hospital-Based Breast Cancer Screening.
PubMed 文献 · Acad Radiol · 2026-01-12

回顾性研究比较2022–2023年移动乳腺X线筛查车(MMU,n=97)与城市医院(n=236)筛查人群的召回率、诊断解决时间及社会人口学因素。BI-RADS 0筛查患者中,MMU组诊断解决中位时间更长(28天 vs 11天,p<0.001),且更多未返回推荐诊断影像检查(18% vs 3.8%,p<0.001)。研究提示需通过患者导航、社工支持和财务援助促进异常筛查的及时随访。

要点

  • MMU筛查召回率显著高于医院筛查(18.8% vs 9.9%)。
  • MMU筛查BI-RADS 0患者诊断解决中位时间更长(28天 vs 11天)。
  • 无保险患者诊断解决可能性更低(HR 0.42,95% CI 0.26–0.69)。

核心结论

  • MMU虽可改善筛查可及性,但异常筛查的及时与公平随访需要改进患者导航、社工支持和财务援助。

研究设计与样本

  • 回顾性研究,分析2022年和2023年两个重叠两周期间在移动乳腺X线筛查车与城市医院系统接受筛查的乳腺X线患者。
  • 主要分析队列为BI-RADS 0(不完整)筛查乳腺X线患者,共333例(MMU 97例,医院236例)。
  • 诊断解决定义为筛查至诊断性乳腺X线BI-RADS 1(阴性)、2(良性)或3(可能良性),或筛选至活检(BI-RADS 4或5)。
  • 采用卡方检验、方差分析和Kruskal-Wallis检验比较两组特征,Cox回归分析评估诊断解决相关因素。

诊断标准与关键数值

  • MMU组召回率为18.8%,医院组为9.9%(p<0.001)。
  • BI-RADS 0患者中,MMU组诊断解决中位时间为28天(IQR 15–51),医院组为11天(IQR 7–20),p<0.001。
  • 无保险患者诊断解决的可能性较低,HR 0.42(95% CI 0.26–0.69,p=0.001)。
  • MMU组17/97(18%)未返回推荐诊断影像检查,医院组9/236(3.8%),p<0.001。

临床应用与阅片要点

  • 影像报告系统需标记筛查来源(移动筛查车或医院),便于追踪异常筛查的随访完成情况。
  • 对MMU筛查的BI-RADS 0病例应加强召回提醒,因其未返回诊断检查的比例显著较高。
  • 无保险或缺少初级保健医生的患者需额外关注随访依从性,可纳入导航或社工协调流程。

局限性

  • 回顾性研究设计,可能存在选择偏倚和信息偏倚。
  • 仅纳入两个重叠两周期间的筛查数据,样本量有限,且为单中心初步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: Breast cancer screening via mobile mammography units (MMUs) can improve access in medically underserved communities. This study aims to evaluate factors associated with screening site, recall rates, and time to diagnostic resolution.

MATERIALS AND METHODS: This retrospective study analyzed recall rates, time to diagnostic resolution, and sociodemographic factors in patients who underwent screening mammograms in an MMU versus urban hospital system during overlapping two-week periods in 2022 and 2023. For patients with BI-RADS 0 (incomplete) screening mammograms, our main analytic cohort, time intervals between screening and diagnostic imaging and, when indicated, between diagnostic imaging and biopsy, were measured. Diagnostic resolution was defined as time from screening to BI-RADS 1 (negative), 2 (benign), or 3 (probably benign) on diagnostic mammogram or, when indicated (BI-RADS 4 or 5 [suspicious or highly suspicious for malignancy, respectively]), from screening to biopsy. Chi-square, analysis of variance, and Kruskal-Wallis tests were performed to compare MMU- and hospital-screened women's characteristics. Cox regression analysis was used to assess factors associated with diagnostic resolution.

RESULTS: In the MMU cohort (n = 97) versus the hospital-based cohort (n = 236), more patients identified as Non-Hispanic Black (68% versus 40%), were uninsured (71% versus 2.1%), and had no primary care provider (35% versus 9.8%, all p<0.001). The MMU cohort also had a higher recall rate (18.8% versus 9.9%, p<0.001). Among BI-RADS 0 screening mammograms (n = 333), time to diagnostic resolution was longer among MMU- versus hospital-screened women (median 28 [IQR 15-51] vs 11 days [IQR 7-20], p<0.001). Patients with no insurance had a lower likelihood of diagnostic resolution (HR 0.42, 95% CI [0.26,0.69], p = 0.001). In the MMU cohort, 17/97 (18%) did not return for the recommended diagnostic imaging versus 9/236 (3.8%) in the hospital-screened cohort (p<0.001).

CONCLUSION: Although MMUs can improve access, our pilot study highlights opportunities to promote timely and equitable follow-up of abnormal screening mammograms through improved patient navigation, social-work support, and financial assistance.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Zeballos Torrez, Edmonds, Nunes, et al. Time to Diagnostic Resolution in Mobile Mammography Versus Urban Hospital-Based Breast Cancer Screening. Acad Radiol. 2026. PMID: 41530030. doi:10.1016/j.acra.2025.12.051

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。